Scaling transcriptomics for high-throughput drug discovery
Join our webinar to discover how 1536-well DRUG-seq unlocks large-scale compound profiling, reveals mechanisms of action and accelerates drug discovery.
Register now
Discovery
Helping you to achieve key decision milestones through deep scientific insights, innovation and collaboration.
Learn More
Preclinical
Enabling you to successfully develop and de-risk your preclinical candidates for a smooth transition to the clinic.
Learn More
Digital
Empowering your drug discovery and development with integrated data services, machine learning and generative AI.
Learn MoreResearch phases
Supporting you with integrated, tailored solutions at every step of your drug discovery and development journey.
Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.
Our science
News and events
Nuvisan strengthens client support through European-Indian hybrid chemistry model
The opening of a new ALS synthesis laboratory in Hyderabad expands Nuvisan's chemistry service offering - connecting scalable chemistry resources in India with Nuvisan's scientific expertise and client engagement.
Learn More about Nuvisan strengthens client support through European-Indian hybrid chemistry modelNuvisan receives US$25 million grant to advance novel non-hormonal contraceptive drug discovery
Nuvisan joins IHI project LIGAND-AI to help advance AI-driven drug discovery through open science
Nuvisan announces the winners of the 3rd Drug Discovery Innovation Challenge 2026
ALS' strategic acquisition drives innovation and science
